SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOVOLENTA, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.273
EU - Europa 4.381
AS - Asia 3.297
SA - Sud America 536
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 87
OC - Oceania 8
Totale 15.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.083
FI - Finlandia 1.972
SG - Singapore 1.302
CN - Cina 769
PL - Polonia 596
IT - Italia 508
BR - Brasile 429
DE - Germania 375
VN - Vietnam 368
HK - Hong Kong 242
GB - Regno Unito 203
UA - Ucraina 190
TR - Turchia 159
SE - Svezia 133
FR - Francia 106
CA - Canada 104
JP - Giappone 88
IN - India 83
RU - Federazione Russa 82
BD - Bangladesh 76
ID - Indonesia 60
MX - Messico 56
AR - Argentina 45
BE - Belgio 44
NL - Olanda 38
ZA - Sudafrica 37
ES - Italia 36
IQ - Iraq 28
CO - Colombia 23
PK - Pakistan 19
IE - Irlanda 17
UZ - Uzbekistan 15
AT - Austria 13
KE - Kenya 13
LT - Lituania 13
SA - Arabia Saudita 12
MA - Marocco 11
MY - Malesia 11
JM - Giamaica 10
PH - Filippine 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
EG - Egitto 8
CL - Cile 7
RO - Romania 7
VE - Venezuela 7
AU - Australia 6
CH - Svizzera 6
HR - Croazia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
HN - Honduras 5
PY - Paraguay 5
UY - Uruguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
KG - Kirghizistan 4
LB - Libano 4
OM - Oman 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
CR - Costa Rica 3
IL - Israele 3
JO - Giordania 3
KR - Corea 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BO - Bolivia 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GL - Groenlandia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
Totale 15.577
Salva come PNG Salva come JPEG
Città #
Helsinki 1.888
Ashburn 806
Singapore 788
San Jose 608
Warsaw 591
Woodbridge 555
Fairfield 515
Ann Arbor 386
Houston 335
Chandler 322
Santa Clara 279
Beijing 255
Hong Kong 238
Jacksonville 220
Seattle 219
Council Bluffs 213
Wilmington 201
Cambridge 174
Dallas 141
New York 140
Ferrara 135
Los Angeles 133
Ho Chi Minh City 126
Munich 124
Izmir 96
Hanoi 85
Nanjing 83
Tokyo 83
Milan 80
Princeton 60
Lauterbourg 52
Shanghai 52
San Diego 50
Boardman 49
London 46
Jakarta 45
São Paulo 44
Toronto 39
Turku 39
Brussels 38
Bremen 37
Mexico City 37
Buffalo 34
Chicago 32
Dearborn 30
Orem 30
Frankfurt am Main 27
Johannesburg 27
Bologna 24
Brooklyn 24
The Dalles 24
Chennai 23
Falls Church 23
Nanchang 23
Tianjin 23
Montreal 22
Phoenix 22
Shenyang 20
Denver 18
Nuremberg 18
Poplar 18
Stockholm 18
Atlanta 17
Hefei 17
Kunming 16
Moscow 16
Rio de Janeiro 16
Rome 15
Boston 14
Changsha 14
Des Moines 14
Brasília 13
Columbus 13
Da Nang 13
Hebei 13
Nairobi 13
Tashkent 13
Belo Horizonte 12
Dong Ket 12
Haiphong 12
Redwood City 12
Curitiba 11
Hangzhou 11
Jinan 11
Newark 11
Ottawa 11
Washington 11
Auburn Hills 10
Baghdad 10
Charlotte 10
Falkenstein 10
San Mateo 10
Ankara 9
Bari 9
Dublin 9
New Delhi 9
San Francisco 9
Brno 8
Mountain View 8
Naples 8
Totale 11.337
Salva come PNG Salva come JPEG
Nome #
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.061
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 484
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 433
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 413
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 366
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 311
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 295
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 294
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 287
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 286
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 282
Crispr/Cas9-based COL7A1 editing for recessive dystrophic epidermolysis bullosa 282
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 279
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 279
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 279
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 276
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 276
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 276
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 270
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 258
Autosomal recessive Bethlem myopathy 253
Exon skipping-mediated dystrophin reading frame restoration for small mutations 251
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 246
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 231
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 230
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 214
Transcriptional behavior of DMD gene duplications in DMD/BMD males 213
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 212
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 211
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 211
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 211
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 203
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 201
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 197
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 183
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 181
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 179
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 176
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 171
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to titin 168
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 168
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 165
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 163
Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 159
null 155
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 152
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 151
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 151
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 149
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 149
Autosomal recessive Bethlem myopathy 147
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 147
Studio di CNVs nel locus HLA (6p21.32) mediante Array CGH in pazienti con Sclerosi Multipla e malformazioni venose 146
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 143
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach 142
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 138
Transcriptional enhancement as therapeutic approach of coagulation factor VII promoter mutations 136
null 131
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 131
A new rat model for Duchenne muscular dystrophy generated by CRISPR-induced deletion of Exon 45 122
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 119
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 116
Efficient generation of mouse models with the CRISPR/Cas9 technology 115
null 113
Targeted Genome Editing in Spinal Muscular Atrophy 90
null 86
A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions 36
Totale 15.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 0 47 37 33 35 67 38 31 62 86 214
2022/2023812 75 82 8 111 154 93 52 63 85 11 44 34
2023/2024435 35 47 37 10 35 97 10 30 10 5 12 107
2024/20251.968 41 30 158 119 254 149 88 98 400 158 274 199
2025/20266.885 514 156 409 581 768 325 652 281 2.293 498 197 211
2026/2027424 138 224 62 0 0 0 0 0 0 0 0 0
Totale 15.749